Wellgistics Health Finalizes Reverse Stock Split Plan to Avoid Nasdaq Delisting
WGRX is trading near its 52-week low of $0.095 (11% above the low).
Summary
Wellgistics Health has finalized plans for a reverse stock split (1-for-25 to 1-for-200) to address Nasdaq's minimum bid price requirement and avoid delisting, following prior disclosures of financial distress.
Key Events · Corporate Governance and Compliance · WGRX
-
Reverse Stock Split Approved
The Board and majority shareholders have approved a reverse stock split with a ratio between 1-for-25 and 1-for-200, to be determined and implemented within 12 months. This follows the preliminary filing on March 24, 2026.
-
Nasdaq Delisting Threat
The primary purpose of the reverse split is to increase the stock price to meet Nasdaq's $1.00 minimum bid price requirement, following a delisting notice received on December 10, 2025. The company has until June 8, 2026, to regain compliance.
-
No Guarantee of Compliance
The company explicitly states there is no assurance the split will result in a sustained higher stock price, long-term Nasdaq listing, or improved liquidity, and warns of potential for lower market capitalization.
-
Authorized Shares Unchanged
The number of authorized shares remains 500,000,000, which could lead to significant dilution if new shares are issued post-split.
Analysis · WGRX · Trade & Services
This definitive information statement confirms the Board's and majority shareholders' approval for a reverse stock split, with a ratio ranging from 1-for-25 to 1-for-200, to be implemented within 12 months. This action is a direct response to the Nasdaq minimum bid price requirement, which the company failed to meet, as previously disclosed in its 10-K filing on March 20, 2026. While necessary to potentially regain Nasdaq compliance, the filing explicitly warns that the split does not guarantee a sustained higher stock price or long-term listing, and could lead to reduced liquidity and a lower overall market capitalization. This move is critical for the company's immediate listing survival, but it highlights ongoing financial distress and the challenges of maintaining exchange compliance.
At the time of this filing, WGRX was trading at $0.11 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $10.6M. The 52-week trading range was $0.10 to $7.04. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.